Therapists Are Reckoning with Eco-anxiety
With no training, counselors feel unequipped to handle the growing number of people anxious about the climate emergency
With no training, counselors feel unequipped to handle the growing number of people anxious about the climate emergency
Shipwreck victims cast adrift for weeks or months exhibit a resilience that serves as a model to weather any extended crisis
For the first time, a randomized controlled trial shows the psychedelic offers potent, if short-term, relief in comparison with an SSRI
Tech-based solutions could offer hope
Phone calls may be integral to connecting with people who are lonely and isolated
Open speculation about his mental health plagued the artist Edvard Munch. In his most famous work, he left a biting commentary
Persistent rumination may be an attribute that lets us think our way out of despair—a process enhanced through talk therapy
Finding meaning for life’s milestones—in my case growing a child—can seem bizarre in COVID isolation
The treatments of the future may arise from a long-stigmatized class of drugs
A technique known as psychological first aid could help reduce COVID stress and anxiety
Deaths are surging, and mental health is strained. But coping strategies people use amid other catastrophes can help
This time of year tends to be a roller coaster of ups and downs, but 2020, unsurprisingly, poses unique challenges
Oregon became the first state to legalize therapeutic use of the drug as new research affirms its benefits for treating depression
The rise in depression and anxiety is even worse than expected, especially among young adults
Brain-scan studies hint that the ancient practice may benefit areas associated with memory, emotion and thinking
Stanford neurobiologist Andrew Huberman discusses the two things we can always control, even during a high-stress election and scary COVID pandemic
Depression and anxiety have risen amid the pandemic; immersive therapeutics can help
Scientific American’s senior medicine editor Josh Fischman talks about issues in medicine and public health that will be affected by this election.
Journalist Robert Whitaker is more concerned than ever that psychiatric medications do more harm than good
A new mental health treatment using the psychedelic compound psilocybin raises questions about medicine and values
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account